Clinical Trials Arena on MSN
Ipsen’s Bylvay fails in Phase III biliary atresia study
There are no approved pharmacological treatments for biliary atresia, which is the leading cause of paediatric liver transplant.
Bile acid metabolism suppression was linked to colorectal cancer prognosis and a 15 gene signature predicted overall survival ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results